Search Results

Aesculap, Inc., a market leader in sterile container systems, has launched AESCULAP Aicon® RTLS, which pairs real-time location service technology with the AESCULAP Aicon® Sterile Container System to help improve the efficiency of Sterile Processing Departments.

Aesculap, Inc. announced today its receipt of FDA 510(k) clearance for DIR800 3D digital infrared fluorescence for use with its Aesculap Aeos Robotic Digital Microscope

True Digital Surgery (TDS) and Aesculap, Inc. today announced that the Aesculap Aeos™ Robotic Digital Microscope is now available in the United States.

Under this agreement, Aesculap is an awarded vendor in the product categories of Cerebral Spinal Fluid Management and Dural Repair

Aesculap, Inc., an industry leader in sterile processing and operating room solutions, is pleased to announce its strategic partnership with Ascendco Health, an emerging health tech company.

Aesculap Implant Systems, LLC, a leader in lumbar motion preservation technology, today announced the e-publication of the “Final Long-Term Reporting from a Randomized Controlled IDE Trial for Lumbar Artificial Discs in Single-Level Degenerative Disc Disease, 7-Year Results” in the International Journal of Spine Surgery.

Aesculap, Inc. is sponsoring the symposium as part of its participation in the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Virtual Meeting [11-August-2020] CENTER VALLEY, Pa. , Aug. 11, 2020 /PRNewswire/ -- Aesculap, Inc. is pleased to announce its participation as a virtual exhibitor at the 2020 Society of American Gastrointestinal and Endosc

Aesculap Inc., in partnership with The Christoph Miethke GmbH & Co. KG (MIETHKE), is pleased to announce the launch of the M.blue valve, the latest generation of Hydrocephalus valve technology

Aesculap Implant Systems, LLC today announced that it has been five years since the organization received FDA approval to market the activL® Artificial Disc in the United States.